by Stem Cell Network | Nov 3, 2010
Yesterday, for the first time in seven years, the House of Commons Standing Committee on Health heard testimony on the current status of stem cell research in Canada. Although the topics covered by MPs during the Committee hearings did not seem to reflect any...
by Stem Cell Network | Nov 2, 2010
Although the use of umbilical cord blood for different medical treatments has been around since 1988, when the first transplant of cord blood was used to treat a patient with Fanconi’s anemia, it’s still a relatively new development in the area of regenerative...
by Stem Cell Network | Oct 22, 2010
In recent years the Stem Cell Network has worked closely with its international colleagues to shed light on clinics offering “stem cell” therapies for which there is scant scientific evidence. One such initiative is A Closer Look at Stem Cell Treatments, a web...
by Stem Cell Network | Oct 21, 2010
For those who follow this blog, you will no doubt know that we are great supporters of the work of Drs. Jim Till and Ernest McCulloch. So, we were thrilled to learn earlier this month that the “fathers of stem cell science” will be honoured today with an...
by Chris Kamel | Oct 19, 2010
As mentioned in a previous post, in order to fully understand what’s happening when stem cells are used for in clinical or in vivo research, we need some way to track them, preferably in a non-invasive manner. This can be done with either reporter genes or some...
by Stem Cell Network | Oct 18, 2010
by Drew Lyall Earlier this month, the Stem Cell Network was delighted to be honoured at the World Stem Cell Summit in Detroit with the 2010 Stem Cell Action Education Award. Presented by the Genetics Policy Institute (GPI), the leading stem cell advocacy organization...
by Chris Kamel | Oct 14, 2010
The reprogramming of differentiated adult cells into induced pluripotent stem (iPS) cells is accomplished by the expression of a small number of key genes. This is typically done by introducing DNA either by transfection or with viral vectors. Current methods,...
by Allison Van Winkle | Oct 8, 2010
High-throughput screening, in which many cell culture conditions can be tested using a combination of robotics, control software, and/or highly sensitive detection, allows researchers to explore new ideas quickly; thousands of combinations can be efficiently tested...
by Katie Moisse | Oct 6, 2010
Day two of the World Stem Cell Summit featured a much-anticipated update on a groundbreaking clinical trial launched in January to assess the safety and feasibility of injecting fetal stem cells into the spinal cords of people with Amyotrophic Lateral Sclerosis (ALS)....
by Stem Cell Network | Oct 4, 2010
What happens when two great scientists sit down for a one-on-one to talk about their work, their mentors and what motivates them? Yes, you get some great chemistry, but more than that, you get a fascinating look at the people and process behind the identification of...
Comments